Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Togni

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Frontiers in Cardiovascular Medicine|December 20, 2021
Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary InterventionsDaphné Doomun, Ianis Doomun, Sara Schukraft, et al.
Heart (British Cardiac Society)|November 10, 2009
Coronary collateral growth by external counterpulsation: a randomised controlled trialSteffen Gloekler, Pascal Meier, Stefano F de Marchi, et al.
Swiss Medical Weekly|January 15, 2016
Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds--an optical coherence tomography substudy of the EVERBIO II trialZacharenia Kallinikou, Diego Arroyo, Mario Togni, et al.
Swiss Medical Weekly|August 30, 2013
Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) and contrast-induced acute kidney injury after coronary angiogramTilman Perrin, Eric Descombes, Jean-Luc Magnin, et al.
Journal of the American College of Cardiology|May 21, 2011
Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularizationLorenz Räber, Peter Jüni, Eveline Nüesch, et al.
Frontiers in Cardiovascular Medicine|October 18, 2021
Bleeding Risk Profile in Patients on Oral Anticoagulation Undergoing Percutaneous Coronary Interventions: A Prospective 24 Months Cohort StudySara Schukraft, Tibor Huwyler, Cindy Ottiger-Mankaka, et al.
JACC. Cardiovascular Interventions|June 6, 2017
Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent)Georgios J Vlachojannis, Pieter C Smits, Sjoerd H Hofma, et al.
European Heart Journal|January 31, 2012
Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantationStéphane Cook, Parham Eshtehardi, Bindu Kalesan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 25, 2013
How should I treat a left main spontaneous dissection involving left anterior descending artery, intermediate branch artery and left circumflex artery?Chiara Bernelli, Silvia Ajello, Daniela Piraino, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 12, 2011
Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) studySerban Puricel, Patrick Adorjan, Markus Oberhänsli, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Frontiers in Cardiovascular Medicine|December 20, 2021
Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary InterventionsDaphné Doomun, Ianis Doomun, Sara Schukraft, et al.
Heart (British Cardiac Society)|November 10, 2009
Coronary collateral growth by external counterpulsation: a randomised controlled trialSteffen Gloekler, Pascal Meier, Stefano F de Marchi, et al.
Swiss Medical Weekly|January 15, 2016
Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds--an optical coherence tomography substudy of the EVERBIO II trialZacharenia Kallinikou, Diego Arroyo, Mario Togni, et al.
Swiss Medical Weekly|August 30, 2013
Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) and contrast-induced acute kidney injury after coronary angiogramTilman Perrin, Eric Descombes, Jean-Luc Magnin, et al.
Journal of the American College of Cardiology|May 21, 2011
Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularizationLorenz Räber, Peter Jüni, Eveline Nüesch, et al.
Frontiers in Cardiovascular Medicine|October 18, 2021
Bleeding Risk Profile in Patients on Oral Anticoagulation Undergoing Percutaneous Coronary Interventions: A Prospective 24 Months Cohort StudySara Schukraft, Tibor Huwyler, Cindy Ottiger-Mankaka, et al.
JACC. Cardiovascular Interventions|June 6, 2017
Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent)Georgios J Vlachojannis, Pieter C Smits, Sjoerd H Hofma, et al.
European Heart Journal|January 31, 2012
Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantationStéphane Cook, Parham Eshtehardi, Bindu Kalesan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 25, 2013
How should I treat a left main spontaneous dissection involving left anterior descending artery, intermediate branch artery and left circumflex artery?Chiara Bernelli, Silvia Ajello, Daniela Piraino, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 12, 2011
Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) studySerban Puricel, Patrick Adorjan, Markus Oberhänsli, et al.
Pageof 13